Inventor
EDWARD T. MAGGIO
Inventor
US
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes67%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
PatentTitleYear
12,337,061Administration of benzodiazepine compositions202512,324,838Intranasal epinephrine formulations and methods for the treatment of disease202512,324,852Administration of benzodiazepine compositions202512,268,664Administration of benzodiazepine compositions202511,918,655Intranasal epinephrine formulations and methods for the treatment of disease202411,793,786Administration of benzodiazepine compositions202311,744,895Intranasal epinephrine formulations and methods for the treatment of disease202311,717,571Intranasal epinephrine formulations and methods for the treatment of disease202311,458,091Compositions and methods for the treatment of opioid overdose202211,241,414Administration of benzodiazepine compositions202211,191,838Intranasal epinephrine formulations and methods for the treatment of disease202111,173,209Compositions for drug administration2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to AEGIS THERAPEUTICS LLC (7)· patent assignee history
2021–2025Based in US· patent location history
2022–2025Patents assigned to NEURELIS INC (5)· patent assignee history
2022Patents assigned to OPIANT PHARMACEUTICALS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AEGIS THERAPEUTICS LLC | 7 | 2021–2025 |
| NEURELIS INC | 5 | 2022–2025 |
| OPIANT PHARMACEUTICALS INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 12 | 2021–2025 |